Global pharma giant GlaxoSmithKline (GSK) is open to making acquisitions in India, Andrew Witty, chief executive officer said on Monday.

The acquisition by Merck KGaA, the world’s oldest pharmaceutical company, of US-based life sciences company Millipore Corporation, would create a business worth close to Rs 900 crore in India for the German drug and chemical major. Further, the acquisition will enable Merck to access new markets in India for bio-pharma and bio-processing solutions and analytical tools for research and development, said analysts.

Pharma firm Strides Arcolab today said it has entered into an agreement with South Africa-based Aspen to acquire the latters facility in Brazil for $75 million (nearly Rs. 343 crore).

Valeant Pharmaceuticals International has entered into an agreement with Spear Pharmaceuticals, Inc. for rights to commercialize Refissa, a prescription-based topical tretinoin cream used to diminish fine wrinkles and fade irregular pigmentation due to sun damage.